Bolt Biotherapeutics BOLT Cash Flow Statement (2020-2026)

NASDAQ BOLT
$3.24 -0.07 (-2.11%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-62.94M-28.99M-27.91M-58.24M-57.77M-21.50M-50.09M-51.77M-48.88M-11.84M-16.69M-21.45M-16.63M-20.55M-12.30M-42.76M-40.07M-8.57M-8.65M-37.05M
Depreciation and Depletion (Quarter)
0.30M0.40M0.40M0.40M0.40M0.50M0.50M0.40M0.50M0.50M1.80M0.40M0.50M0.40M0.40M0.30M0.30M0.30M0.20M0.20M
Share-based Compensation (Quarter)
2.23M2.14M2.92M2.39M2.14M2.12M2.48M2.35M2.33M-7.16M2.30M2.83M1.10M0.18M0.71M0.62M0.41M1.04M0.55M0.55M
Asset Writedowns and Impairment (Quarter)
0.81M
Cash from Operations (Quarter)
-6.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.82M-0.82M-0.47M-0.23M0.04M0.47M0.85M1.11M1.33M1.19M1.03M0.79M0.48M0.31M0.21M0.17M0.13M0.16M0.04M0.08M
Amortization of Deferred Charges (Quarter)
0.76M0.54M1.17M0.67M0.68M0.70M0.72M0.73M0.74M0.76M0.77M0.79M0.80M-0.07M0.61M0.62M0.64M0.65M0.67M0.68M
Depreciation & Amortization (CF) (Quarter)
0.30M0.36M0.36M0.41M0.44M0.46M0.47M0.46M0.46M0.47M0.46M0.46M0.44M0.43M0.40M0.35M0.29M0.26M0.20M0.17M
Change in Working Capital
Change in Accured Expenses (Quarter)
0.20M
Other Working Capital Changes (Quarter)
-0.03M
Investing Activities
Capital Expenditures (Quarter)
1.01M-0.76M0.60M0.43M0.73M0.18M0.05M-0.01M0.17M-0.05M0.04M0.00M0.07M
Sales of Property, Plant and Equipment (Quarter)
0.70M
Change in Acquisitions & Divestments (Quarter)
7.10M
Cash from Investing Activities (Quarter)
7.77M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
5.62M7.23M10.71M0.57M0.46M
Net Equity Issued and Repurchased (Quarter)
0.02M
Misc.
Cash from Financing Activities (Quarter)
0.02M
Change in Cash (Quarter)
1.25M
Free Cash Flow (Quarter)
-6.54M
Net Cash Flow (Quarter)
1.25M